Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) Cost of Revenue & History | Stock Alarm

Demo Sign up Log In

Bio-Rad Laboratories, Inc. Class A Common Stock · Cost of Revenue

BIO Cost of Revenue

Latest reported$1.25Bperiod endingJun 30, 2026

BIO Cost of Revenue ($45.60M → $1.25B)

Annual cost of revenue

High-resolution chart · PNG

BIO cost of revenue history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bio-Rad Laboratories, Inc. Class A Common Stock Cost of Revenue — Annual fiscal periods (USD)
Period ending	Cost of Revenue (USD)
Dec 31, 2025	1,239,600,000
Dec 31, 2024	1,187,600,000
Dec 31, 2023	1,244,316,000
Dec 31, 2022	1,234,919,000
Dec 31, 2021	1,284,449,000
Dec 31, 2020	1,107,739,000
Dec 31, 2019	1,054,663,000
Dec 31, 2018	1,065,747,000
Dec 31, 2017	972,754,000
Dec 31, 2016	930,085,000
Dec 31, 2015	897,771,000
Dec 31, 2014	996,527,000
Dec 31, 2013	954,216,000
Dec 31, 2012	908,190,000
Dec 31, 2011	895,640,000
Dec 31, 2010	835,630,000
Dec 31, 2009	784,401,000
Dec 31, 2008	801,843,000
Dec 31, 2007	669,690,000
Dec 31, 2006	561,394,000
Dec 31, 2005	534,499,000
Dec 31, 2004	479,939,000
Dec 31, 2003	437,990,000
Dec 31, 2002	383,235,000
Dec 31, 2001	356,330,000
Dec 31, 2000	300,055,000
Dec 31, 1999	227,700,000
Dec 31, 1998	181,500,000
Dec 31, 1997	169,900,000
Dec 31, 1996	164,100,000
Dec 31, 1995	155,200,000
Dec 31, 1994	139,000,000
Dec 31, 1993	134,400,000
Dec 31, 1992	124,300,000
Dec 31, 1991	122,200,000
Dec 31, 1990	113,300,000
Dec 31, 1989	95,300,000
Dec 31, 1988	81,500,000
Dec 31, 1987	63,500,000
Dec 31, 1986	52,700,000
Dec 31, 1985	45,600,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.